The OMEGA Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 328 participants.

Also called NCT01419171

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 328 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01419171
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, France, Germany, Latvia, Netherlands, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01419171. Allocation not applicable; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2014-08-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The OMEGA Clinical Trial
Condition
Atherosclerosis
Intervention (Device)
OMEGA™ Monorail Coronary Stent System
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01419171
Content hash
d9b4df7ef5c7e0fda11ff965be54a72c63c0443bbb00406ea163fe113cbe7be7